The people in these photos are not actual Rebif® patients.
The well-established safety profile of Rebif® is supported by more than 20 years of combinedclinical trial data and real-world patient experience. Safety is an important topic to discuss with your healthcare provider when choosing a relapsing multiple sclerosis (RMS) treatment.
Rebif® is an immunomodulator, a medication used to help regulate the immune system. It doesn’t continuously suppress your immune system.
Behavioral health problems including depression and suicidal thoughts
Liver problems or worsening of liver problems including liver failure
Serious allergic and skin reactions
Injection site problems
Blood problems
Seizures
Flu-like symptoms
Stomach pain
Change in liver blood tests
When you take Rebif®, you can also count on the full support of MS LifeLines® Nurses. They can help answer many questions about relapsing forms of MS and treatment with Rebif®, including proper injection techniques.
When you take a medication, safety and tolerability are 2 important terms to understand.
Safety refers to things that can happen, related to treatment with a drug, that may require medical attention, or constitute a medical risk.
Tolerability is related to how a drug makes you feel when you are taking it, like when you’re experiencing side effects from a treatment. Sometimes, people can tolerate certain side effects in order to meet their treatment goals. Other times, side effects can be unbearable, so a change of treatment may be recommended.
It’s important to discuss with your healthcare provider whatever you’re experiencing. They can assess if you require medical attention or adjustment to your treatment. Learn more about possible Rebif® side effects.
The people in these photos are not actual Rebif® patients.
IMPORTANT SAFETY INFORMATION AND INDICATION
Important Safety Information
Do not take Rebif if you are allergic to interferon beta, human albumin, or any of the ingredients in Rebif.
Rebif can cause serious side effects. Tell your healthcare provider right away if you have any of the symptoms listed below while taking Rebif.
Before you take Rebif, tell your healthcare provider if you have or have had any of the following conditions:
Tell your healthcare provider about all medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements.
The most common side effects of Rebif include:
Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of Rebif. For more information, ask your healthcare provider or pharmacist.
Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Indication
Rebif® (interferon beta-1a) is a prescription medicine used to treat relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. It is not known if Rebif is safe and effective in children.
Please see Rebif® Prescribing Information and Medication Guide.